The PPI network suggested that 4a may target related proteins expressed by SRC, EGFR, CCND1, MTOR, MAPK1, PIK3CA, MMP9, MAPK8, MMP2, MAPK14, and other genes, which may be central targets for 4a to exert its anti-breast cancer effects. This evidence concerns the gene MAPK14 and breast cancer.